| For: |
Ruiz-Malagón AJ, Herraiz-Vilela M, Serrano-Pino R, García-Ávila P, |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i41/110955.htm |
| Number | Citing Articles |
| 1 |
Jia Yang, Ya-Ting Pan, Hong-Zhu Wen. Growth differentiation factor 15 - a new molecular target in inflammatory bowel disease: Progress and challenges. World Journal of Gastroenterology 2026; 32(5): 115439 doi: 10.3748/wjg.v32.i5.115439
|
| 2 |
Mohammad Samimi Tanoorjeh, Hossein Shahdadi Sardou, Sara Feizollahi, Prashant Kesharwani, Mohammadreza Abbaspour, Amirhossein Sahebkar. Targeting mitochondrial dysfunction through nanomedicine: a new avenue for inflammatory bowel disease therapy. Microchemical Journal 2026; 224 doi: 10.1016/j.microc.2026.117838
|
| 3 |
Irene Díaz-Alberola, Daniel E. Di Zeo-Sánchez, Vanesa Garrido-Rodríguez, Carlos López-Gómez, Cristina Rodríguez-Díaz, Raul J. Andrade, M. Isabel Lucena, Marina Villanueva-Paz, Eduardo García-Fuentes. The gut–liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system. Acta Pharmaceutica Sinica B 2026; doi: 10.1016/j.apsb.2026.04.014
|